BiotechTube
Home/Intensity Therapeutics/Lewis H. Bender
LH

Lewis H. Bender

Founder, President, and Chief Executive Officer

Intensity Therapeutics

Therapeutic Areas

OncologySolid Tumors

Intensity Therapeutics Pipeline

DrugIndicationPhase
INT230-6Early-Stage Triple-Negative Breast Cancer (Neoadjuvant)Phase 2
DfuseRx PlatformSolid Tumors (Platform Technology)Preclinical